American Journal of Physiology-Gastrointestinal and Liver Physiology · 2001 · 47 citations · 27 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPharmacodynamicsCannabinoid PharmacologyCardiovascular PharmacodynamicsHemodynamic PharmacologyHemodynamic PharmacotherapyPortal HypertensionCannabinoid AntagonistsMesenteric VasculaturePortal EffectsPortal HemodynamicsPortal Vein HemodynamicsPortal Venous Flow DynamicsVascular ResistanceVenous Hemodynamics
The endogenous cannabinoid anandamide causes hypotension and mesenteric arteriolar dilation. A detailed analysis of its effects on systemic and portal venous hemodynamics had not yet been performed. We assessed the effects of anandamide (0.4-10 mg/kg) on systemic and portal hemodynamics with and without prior treatment with various antagonists. The specific antagonists used included SR-141716A, N(omega)-nitro-L-arginine methyl ester, indomethacin, and nordihydroguaiaretic acid. Anandamide produced a dose-dependent decrease in mean arterial pressure due to a drop in systemic vascular resistance (SVR) that was accompanied by a compensatory rise in cardiac output. Anandamide also elicited an increase in both portal venous flow and pressure, along with a decline in mesenteric vascular resistance (MVR). Pretreatment with 3 mg/kg SR-141716A, a CB(1) antagonist, prevented the decline of SVR and MVR from the lower dose of anandamide. Antagonism of nitric oxide synthetase, cyclooxygenase, or 5-lipoxygenase did not prevent the systemic nor the portal hemodynamic effects of anandamide. Furthermore, the use of R-methanandamide, a stable analog of anandamide, produced similar hemodynamic effects on the mesenteric vasculature, thereby implying that the effects of anandamide are not related to its breakdown products. Anandamide produced profound, dose-dependent alterations in both the systemic and portal circulations that could be at least partially blocked by pretreatment with SR-141716A.
27
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
William A. Devane, Aviva Breuer, Roger G. Pertwee et al. · Science · 1992 · 5.6K citations
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Peter M. Zygmunt, Jesper Petersson, David A. Andersson et al. · Nature · 1999 · 2.1K citations